1. Shandong Xinyi Pharmaceutical Co., Ltd., formerly known as Shandong Pingyuan pharmaceutical factory, was founded in 1978. It is a national designated production base of psychotropic drugs and a production base of cardiovascular and cerebrovascular drugs in Shandong Province. In April 2013, it married Sinopharm Xinyi in the industrial sector under Shanghai pharmaceutical, which ranks among the top 500 in the world and the top 50 in the global pharmaceutical industry, and became its subsidiary. It is a comprehensive pharmaceutical enterprise integrating manufacturing, sales and R & D. The current plant covers an area of 38.5 mu; There are 306 employees, with college degree or above accounting for more than 75%; There are 83 product batches, including 62 preparation products, with an annual production capacity of 3 billion tablets; 21 API products with a production capacity of 150 tons. The products involve 8 treatment fields and 4 types of dosage forms, focusing on the research and development in the field of psychotropic drugs and cardiovascular and cerebrovascular fields. The products are sold in all provinces, cities and autonomous regions across the country, and are deeply favored by the majority of users.

          In recent years, with the strong support of municipal and county leaders, the company has been honored as a provincial "contract abiding and trustworthy" enterprise for many years, and has been successively listed as a "1515" project cultivation enterprise in Dezhou, "three 100" project 100 high enterprise, "three navigation" project key escort enterprise, "double recruitment and double introduction" provincial key project support enterprise, and provincial postdoctoral innovation practice base, National high-tech enterprise, provincial enterprise technology center and provincial engineering laboratory, won the "top 50 industrial enterprises in Dezhou City" in 2020, ranking 13th, won the May Day Labor award of Shandong Province in 2021 and a high-end brand cultivation enterprise in Shandong Province.